GM
Therapeutic Areas
CiMaas Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Expanded Donor NK Cells | Cancer | Pre-clinical |
| NK Cell + Antibody Combination | Cancer | Pre-clinical |
| CAR-NK Cell Therapy | Solid Tumors | Research |
| Drug | Indication | Phase |
|---|---|---|
| Expanded Donor NK Cells | Cancer | Pre-clinical |
| NK Cell + Antibody Combination | Cancer | Pre-clinical |
| CAR-NK Cell Therapy | Solid Tumors | Research |